The Cost of Treating Chronic Non-Communicable Diseases: Does it Matter?
Daren Conrad and
Marquitta C. Webb
MPRA Paper from University Library of Munich, Germany
Abstract:
Heart disease and Type 2 diabetes mellitus are among the two leading causes of death in the CARICOM member states with HIV/AIDS a distant sixth. Attention is now being paid to non-communicable diseases which have outpaced communicable diseases as the major cause of death. This paper investigated the link between the public medical cost of treating chronic non-communicable diseases, namely heart disease and diabetes, on national output in Barbados, Guyana, Jamaica, and Trinidad and Tobago. The results provide evidence that the public medical cost of treating chronic non-communicable diseases does have a statistically significant negative impact on national output.
Keywords: Non-Communicable Diseases; Caribbean Development; Economic Growth (search for similar items in EconPapers)
JEL-codes: H51 (search for similar items in EconPapers)
Date: 2012-06-15, Revised 2012-10-01
New Economics Papers: this item is included in nep-hea
References: Add references at CitEc
Citations:
Downloads: (external link)
https://mpra.ub.uni-muenchen.de/42520/1/MPRA_paper_42520.pdf original version (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:42520
Access Statistics for this paper
More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter (winter@lmu.de).